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1. Introduction 
Infectious disease is one of the most concerning health issues worldwide. To provide 
patients with effective medical treatment and prevent the spread of diseases and emergence 
of drug-resistant strains, quick and reliable diagnostic techniques are in high demand. 
However, lack of accessibility to such diagnostic systems has resulted in the deterioration of 
the situation in most developing countries, especially in sub-Saharan tropical countries 
(Rodrigues et al., 2010). Diagnostics using molecular technologies have emerged as a 
promising methodology because of their remarkable high sensitivity, and therefore, they 
have been applied as diagnostic tools for detecting various kinds of pathogens in clinical 
settings in developed countries. However, resources essential for molecular assays, such as 
bio-safety cabinets, a stable supply of electricity, and well-experienced technicians, are 
scarce in most of the peripheral laboratories in developing countries. In this chapter, we 
would like to describe a recently developed novel diagnostic platform and discuss its 
application for realizing molecular diagnostics for infectious diseases within resource-
limited settings. 
Molecular diagnostics comprise the following 3 steps: sample preparation, amplification, 
and detection. To develop a molecular diagnostic platform with the desired simplicity and 
performance, it is necessary to introduce element technologies for all the 3 steps, which are 
less complicated and can be used in peripheral laboratories with limited resources. Of the 
abovementioned 3 steps, amplification of target DNA/RNA is the most important. 
Therefore, the loop-mediated isothermal amplification (LAMP) method involving the 
calcein detection method has been applied to the platform as a key technology. LAMP, 
using the calcein method, enables recognition of small quantities of DNA/RNA of 
pathogens present in clinical specimens by means of the fluorescence emitted from the 
LAMP solutions after amplification.  
The next important step is sample processing, for which we have developed a simple and 
easy-to-use technology, namely, procedure for ultra rapid extraction (PURE). The 
combination of both these technologies can be considered a novel platform for molecular 
diagnostics, which can be applied to resource-limited settings. The fundamental 
characteristics of these element technologies and application of the novel platform to 
diagnostics for evaluation of certain tropical diseases are discussed below. 
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2. Steps involved in molecular diagnostics 
2.1 Amplification – LAMP 
Since the publication of the first report regarding LAMP in 2000 (Notomi et al., 2000), LAMP 
has been used to detect different kinds of pathogens (Mori & Notomi, 2009), including 
viruses (Kubo et al., 2010), bacteria (Iwamoto et al., 2003), and protozoa (Spencer et al., 
2010), and thus far, approximately 500 reports have been published regarding the 
application of LAMP. Because the LAMP method is simple and quick, it has been 
considered one of the most ideal nucleic acid amplification methods, which can be applied 
as an easy-to-use and cost-effective genetic test system (Parida et al., 2008). 
2.1.1 Mechanism of LAMP 
Although the reaction mechanism appears complicated, LAMP is simple to perform—it 
involves mixing primers (designed as depicted in figure 1-A), DNA polymerase with strand-
displacement activity, and dNTPs, in a buffer containing magnesium ions, and maintaining 
the mixture at a constant temperature of 60–67 °C for 15–60 minutes. If template DNA 
molecules are present in the sample solution, large quantities of DNA with the target 
sequence (amplicon) are produced after incubation.  
Figures 1-B and C show the schematic representation of the mechanism of LAMP. First, the 
forward inner primer (FIP) anneals to the template DNA at the F2c sequence and the 
extension reaction occurs by the enzymatic activity of Bst polymerase. Because Bst 
polymerase exhibits strand displacement activity, the product obtained from FIP is 
displaced by the other extension reaction associated with the F3 primer. Subsequently, the 
extension reaction occurs from the backward inner primer (BIP) on the product of the FIP, 
and not on the template DNA with a B2c sequence; the product obtained is also displaced 
by DNA synthesis associated with the B3 primer. These reactions result in a product with a 
dumbbell-like structure as shown in figure 1-B. The formation of the dumbbell-like product 
is essential for LAMP to establish isothermal amplification because the loop structures are 
always single stranded and can be annealed by FIP or BIP. Thus, formation of the loop 
structure can lead to the elimination of the denaturing step, which is otherwise essential in 
PCR for obtaining single-stranded DNA. 
After the formation of the dumbbell-like structure, a cyclic reaction is spontaneously 
established between the dumbbell-like structure and its complementary product, as shown 
in figure 1-C. Furthermore, in the course of the cyclic reaction, elongated products with 
various copies of the target sequence are also produced.  
The basic characteristics of the LAMP method are summarized below: 
1. The whole amplification reaction occurs continuously under isothermal conditions, thus 
eliminating the need to use a thermal cycler, which is commonly used for PCR. 
2. Because LAMP primers recognize 6 distinct regions, the specificity of LAMP is much 
higher than that of the other commonly used amplification techniques. 
3. Amplification can be performed using an RNA template only by the addition of reverse 
transcriptase to the reaction (one-step RT-LAMP). 
4. The LAMP reaction can be accelerated by using additional primers, called “loop 
primers,” which are designed between F1c/B1c and F2c/B2c (Nagamine et al., 
2002). 
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Fig. 1. Schematic representation of the mechanism of the LAMP assay 
A) Design of the LAMP primers 
B) Formation of a dumbbell-like structure 
C) Cyclic and elongation reactions 
2.1.2 Strategies that make LAMP simple and cost-effective 
Conventional LAMP reagents are supplied in liquid form, and they have to be stored below 
-20 °C, similar to most PCR reagents. However, because of the lack of a freezer and cold 
chain transportation system in most of the peripheral laboratories in developing countries, it 
is essential to formulate LAMP reagents, which can be stably preserved at ambient 
temperatures (Jorgensen et al., 2006; Aziah et al., 2007). The newly formulated LAMP 
reagents are dried down into the lid of the reaction tubes, thus obtaining preservation 
stability at ambient temperatures for more than 12 months. The dried LAMP reagents can be 
reconstituted quite easily by shaking the tubes after the addition of the purified DNA 
solution. Because the LAMP reagent for each reaction is deposited on the individual tubes in 
advance, there is no longer a need to prepare and dispense master-mix solutions to the 
reaction tubes. Thus, liquid handling using micropipette, one of the most skillful steps, 
becomes unnecessary in the course of the assay. Moreover, this can contribute to reduced 
risk of carryover contamination during the assay. 
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2.2 Detection – Calcein method 
The results of the LAMP assay can be detected visually by observing the strength of the 
green fluorescence emitted after the reaction. Figure 2 represents the mechanism of the 
calcein method (Tomita et al., 2008). Before LAMP amplification, the metalochrome 
indicator “calcein” is quenched by the effect of a manganese ion. After the LAMP reaction, 
pyrophosphate ions (PPi) are produced as a by-product of polymerase reaction; PPi 
subsequently forms a manganese pyrophosphate complex, causing the removal of the 
manganese ion from calcein, because the PPi are a stronger base than calcein. Next, free 
calcein combines with a magnesium ion to produce bright fluorescence. This technology 
enables the detection of LAMP reactions without the use of fluorescence detectors, which 
are usually expensive and difficult to manage in resource-limited settings. Other 
technologies for visual detection using LAMP have also been reported (Tao et al., 2011; Goto 
et al., 2009; Mori et al., 2006). 
 
 
Fig. 2. Mechanism involved using calcein 
2.3 Sample preparation – PURE 
The sample processing method is the next important step in molecular diagnostics. Silica-
based methods are well known and have been applied to a wide variety of samples, 
including blood and tissue (Bendall, 2002). However, these methods are unsuitable for 
resource-limited facilities due to the cumbersome procedures involved, including washing 
with organic solvents using high-speed centrifugation. Therefore, we have developed a 
simple and swift sample processing method named PURE. Thus far, it has been confirmed 
that PURE can be successfully applied to sputum, blood, serum, and swab samples. The 
mechanism of PURE is described below: 
1. An aliquot of sample (blood, sputum, etc.) is added to the alkaline-based extraction 
solution and treated by heat to lyse the pathogens. 
2. The sample solution is treated with adsorbent powder to remove inhibitory materials 
contained in samples and to neutralize the solution without any loss of target DNA. 
3. After separating the solution from the powder by filtration, the obtained filtrate 
containing target DNA molecules can be used for reconstituting dried LAMP reagents, 
which are deposited to the lids of LAMP reaction tubes. 
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Fig. 3. Performance of the PURE–LAMP system applied for blood processing 
A) Pictures of the blood sample solution (3.6% blood in an alkaline-based extraction 
solution) before and after PURE treatment. Left, Before PURE treatment; Centre, After PURE 
treatment; Right, distilled water (reference). 
B) LAMP kinetics obtained by real-time turbidimetry for the 3 sample solutions with 1,000 
copies of a template DNA spiked prior to PURE treatment.Green line, Before PURE 
treatment (directly added the solution to LAMP reaction); Red line, after PURE treatment; 
Blue line, control (distilled water); Purple line, negative control. 
Figure 3 shows the performance of the PURE method applied for blood processing. An 
aliquot of blood was mixed with the extraction solution and heated at 70 °C for 5 minutes. 
Almost colorless solutions have been obtained by mixing the solution with the adsorbent 
powder (Fig. 3-A). The graph of real-time turbidimetry (Mori et al., 2004) in figure 3-B 
shows the LAMP kinetics for the 3 samples using 1,000 copies of a spiked template DNA. 
Untreated blood samples did not provide a positive reaction due to the inhibition from 
blood and extraction solution. However, PURE-treated blood samples showed almost the 
same kinetics as those of distilled water, indicating that PURE can remove inhibitory 
materials quite effectively from the blood samples without any loss of DNA.  
www.intechopen.com
 
Novel Molecular Diagnostic Platform for Tropical Infectious Diseases 
 
451 
Figure 4 shows the overall process of the PURE-LAMP assay system. First, an aliquot of sample 
is placed in a heating tube and heated at an optimized temperature (70–90 °C) to lyse the target 
pathogen. Then, the heating tube is attached to an adsorbent tube, and the treated solution is 
vigorously mixed with adsorbent powder. Next, the injection cap is inserted into the absorbent 
tube, which is then squeezed to elute the solution containing purified DNA. These processes 
can be performed in approximately 10 minutes or less for a particular sample. The LAMP 
reagents deposited in the lid of the tube are reconstituted by shaking the tube several times and 
then incubating it at around 65 °C for 30–40 minutes. Finally, the results of amplification are 
detected by simply observing the fluorescence using the LED lights provided in the incubator. 
As mentioned above, we have successfully developed simple technologies for all the 3 steps 
required in molecular diagnostics, that is, the PURE method for sample preparation, the 
LAMP for amplification, and the calcein method for detection. Therefore, a combination of 
these technologies can be considered as a platform for a new molecular diagnostic tool with 
the desired simplicity.  
3. Application of the newly developed platform for diagnosing tropical 
diseases 
The developed platform has been applied to the following 3 tropical diseases to evaluate its 
performance as a practical diagnostic system.  
3.1 Malaria and human African trypanosomiasis  
Malaria is 1 of the 3 major infectious disease endemics in most tropical countries. More than 
500 million people have been infected, and more than 1 million people die from malaria 
each year, mostly infants and pregnant women. Of the 4 malaria causing species, 
Plasmodium falciparum often causes severe, acute, and fatal malaria. In most developing 
countries, malaria is confirmed mainly by a blood smear test, although the sensitivity of the 
test is not sufficient to detect the parasites in patients with early-stage malaria.  
Dried LAMP reagents using P. falciparum (Pf)-specific primers and pan genus (Pg) primers 
were developed in this study. The Pg LAMP primers were designed on the basis of the 
homogeneous sequence shared by all the 4 malaria species, thus providing the same primer 
specificity for all the 4 species. The Pf-specific LAMP primers were designed based on 
mutations between the Pf sequence and the other 3 sequences, making the primer specific 
only to P. falciparum. If both Pf and Pg LAMP assays give positive results, it can be 
interpreted that the patient is infected by P. falciparum. On the other hand, if only the Pg 
LAMP assay gives positive results, the patient can be diagnosed with malaria caused by 1 or 
more of the other 3 malarial parasites.  
The sensitivity of PURE and malaria-LAMP have been evaluated by using of cultured P. 
falciparum parasites obtained from the American Type Culture Collection (ATCC). As shown 
in figure 5, both Pf and Pg malaria-LAMP assays can detect down to 1 parasite in 1 μl blood, 
processed by the PURE method. This sensitivity of 1 parasite/μl blood is much higher than 
that of smear microscopy test (~50 parasites/μl blood for routine tests in an endemic area 
(Moody, 2002)). It has been reported that the initial malarial symptoms appear after the 
accumulation of approximately 1,000 parasites/ml of blood (Andrews et al., 2005). 
Therefore, PURE-malaria-LAMP is sensitive enough to detect parasites in patients who 
present with the initial symptoms of malaria. 
Human African trypanosomiasis (HAT) is one of the most neglected disease endemics in 
central African countries (Hotez, 2007). HAT is caused by an infection of protozoa 
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Trypanosoma brucei gambiense or Trypanosoma brucei rhodesiense transmitted by tse-tse flies. 
The symptoms of HAT occur in 2 phases: hemolymphatic phase, followed by the 
neurological phase. If left untreated, the hemolymphatic phase permits the parasites to 
invade the central nervous system of the patient, resulting in fatal neurological symptoms 
such as coma and eventually death. Because no vaccine or preventative drug for HAT is 
available, and therapeutic drugs for HAT patients in the neurological phase causes severe 
side effects, a simple and sensitive diagnostic method is in high demand. 
 
 
Fig. 4. Diagram of the procedures involved in the PURE–LAMP system 
 
Fig. 5. Sensitivity of PURE-Malaria-LAMP 
Thirty-five microliters of control blood spiked with cultured parasites (P. falciparum, from 
ATCC) was treated with PURE and tested by P. falciparum-specific and Pan-genus LAMP. 
Left and right tubes contain the same parasite numbers and are those of Pf-LAMP and  
Pg-LAMP, respectively. 
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To enhance sensitivity, the LAMP primers for HAT are designed on a multi-copy gene 
named RIME, which contains 80–250 copies in a parasite genome (Njiru et al., 2008). The 
efficacy of the PURE-HAT-LAMP assay was also evaluated by using uninfected control 
blood spike with cultured parasites. Positive results have been successfully obtained from 
samples with a parasite density of 100/ml, indicating that the overall analytical sensitivity 
of PURE-HAT-LAMP can be estimated to be approximately 100 parasites/ml blood. The 
sensitivities of the currently available smear microscopy tests have been reported to be 
between 100 and 10,000 parasites/ml blood (Chappuis., 2005). The sensitivity of PURE-
HAT-LAMP has been found to be over 10 times higher than that of the simple Giemsa-
stained smear microscopy test, which is one of the most common diagnostic tests in HAT 
endemic areas, and is almost comparable with that of the mini-anion-exchange 
centrifugation technique, which is quite tedious and time consuming. 
3.2 Tuberculosis  
Tuberculosis (TB) is one of the most threatening airborne diseases worldwide. One-third of 
the world's population is thought to be infected with Mycobacterium tuberculosis and new 
infections occur at a rate of about 1/second. Since the TB patients are concentrated in 
developing counties, including many tropical countries, TB is considered as a major 
poverty-related disease (Walker et al., 2003).  
The sputum direct smear microscopy test is the only diagnostic method available for the 
detection of TB at peripheral laboratories in developing countries (Keeler et al., 2006). 
Because of the low sensitivity of the smear test, few patients with a low number of infected 
TB cells are often misdiagnosed as negative, thus preventing eradication of TB. In order to 
overcome this situation, we attempted to apply the novel platform PURE-LAMP system for 
the diagnosis of TB.  
As summarized in Table 1, PURE-TB-LAMP provided positive results for both smear- and 
culture-positive sputum samples collected from patients suspected with TB. Furthermore, 
 
15/25 60
100-200 7/7 100
20-99 6/8 75
1-19 2/10 20
Negative 9/91 9.9Negative
Culture(Ogawa)
Colony
Counts
% positive
34/34 100
Negative
Positive
PURE-TB-LAMP
(Positive/Total)
Direct Smear 
Positive
Positive
 
Table 1. Summary of clinical performance of PURE-TB-LAMP 
Sixty microliters of sputa obtained from patients suspected with TB in the Pham Ngoc 
Thach Hospital (PNTH; Vietnam) were analyzed by PURE-TB-LAMP. The performance of 
PURE-TB-LAMP was compared to those of the direct smear and culture method (Ogawa 
media) in terms of the positive ratios. Smear and culture tests for each sample were 
conducted according to the standardized protocols in PNTH. 
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the PURE-TB-LAMP assay can detect the pathogen with 60% accuracy in smear-negative but 
culture-positive samples, and with 75% or more accuracy if 20 colonies are detected by the 
culture test using Ogawa media. This data clearly shows that the PURE-TB-LAMP method 
is reliable enough to be applied to the targeted peripheral smear centers in developing 
countries as an alternative method for the direct smear test. 
4. Conclusions 
As mentioned above, PURE and LAMP system have been newly developed and successfully 
applied as a novel diagnostic platform for the detection of infectious diseases, which are 
wildly endemic in the developing world. This platform has the advantage of being simple 
enough to be applicable in resource-limited facilities and its performances is higher than 
those of the existing diagnostic methods routinely employed in rural laboratories of most of 
the developing countries. Recently, a novel idea for performing LAMP without electricity 
has been proposed (LaBarre et al., 2011). Combination of that technology with the platform 
mentioned in this chapter would make it possible to realize the use of molecular diagnostics 
in poorer settings or even in field conditions.  
Since the geographical distribution of malaria, HAT, and TB overlap in many of tropical 
countries (Cook & Zumla, 2003), diagnostic tests for these diseases are often performed at 
the same rural laboratory in developing countries. The developed platform described in this 
study is a very useful tool in such laboratories because all the above mentioned diseases can 
be diagnosed using almost the same technique and the same simple incubator. This new 
technology can be beneficial as it reduces the initial costs associated with installing new 
equipments and preparing trained technicians for each target. This platform is potentially 
applicable to other pathogens, including those causing other neglected diseases such as 
leishmaniasis and Chagas’ disease. The application of this platform could be extended to 
other diseases that threaten the heath and quality of life of patients in many tropical 
countries. This can also contribute to distribute them at more affordable rates because of the 
effect of mass production. 
This platform can be considered as a gene point-of-care testing (g-POCT) device, which can 
also be used in developed countries. In fact, TB-LAMP has been approved as clinical in vitro 
diagnostics (IVD) in Japan and used along with PURE as a simple and fast screening test for 
patients suspected with TB. Since NALC-NaOH treatment for sputum is not necessary for 
PURE-TB-LAMP, turn-around-time of PURE-TB-LAMP is less than that of the 
decontaminated smear test, which is commonly adopted as the standard screening test for 
TB in most developed countries. Furthermore, LAMP reagents using similar concepts have 
been developed for the detection of the influenza virus (Nakauchi, 2011). We hope that the 
platform will contribute to the improvement of global health and benefit all those under the 
threat of infectious diseases.  
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